Foundation Research Report issue

Foundation Phase 4

Organization Overview

First Clinical Trial
2001
NCT00304993
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2001

Timeline

NOW
  • Now

Alternative names

Foundation Research, Florida

Active Ingredients

Drugs in Phase 4 Trials (3)

fenofibrate (fenoglide) (1 trial)

niacin (1 trial)

sitagliptin (januvia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dyslipidemias (Phase 4)

Insulin Resistance (Phase 4)

Metabolic Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 3